These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32190734)

  • 61. [Expression and significance of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase in non-melanoma skin cancer].
    Fu XR; Zhang C; Chen CY; Zhang L; Wang LX; Wang BH; Liu XY; Zhang MZ
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):369-73. PubMed ID: 22883459
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in bladder cancer.
    Kanayama H; Yokota K; Kurokawa Y; Murakami Y; Nishitani M; Kagawa S
    Cancer; 1998 Apr; 82(7):1359-66. PubMed ID: 9529029
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Significance of circulating matrix metalloproteinase-9 to tissue inhibitor of metalloproteinases-2 ratio as a predictor of disease progression in patients with metastatic renal cell carcinoma receiving sunitinib.
    Miyake H; Nishikawa M; Tei H; Furukawa J; Harada K; Fujisawa M
    Urol Oncol; 2014 Jul; 32(5):584-8. PubMed ID: 24680659
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Matrix metalloproteinase (MMP)-8 and tissue inhibitor of MMP-1 (TIMP-1) gene polymorphisms in generalized aggressive periodontitis: gingival crevicular fluid MMP-8 and TIMP-1 levels and outcome of periodontal therapy.
    Emingil G; Han B; Gürkan A; Berdeli A; Tervahartiala T; Salo T; Pussinen PJ; Köse T; Atilla G; Sorsa T
    J Periodontol; 2014 Aug; 85(8):1070-80. PubMed ID: 24283658
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of pegylated interferon alpha 2b plus ribavirin treatment on plasma transforming growth factor-beta1, metalloproteinase-1, and tissue metalloproteinase inhibitor-1 in patients with chronic hepatitis C.
    Flisiak R; Jaroszewicz J; Lapinski TW; Flisiak I; Prokopowiczi D
    World J Gastroenterol; 2005 Nov; 11(43):6833-8. PubMed ID: 16425392
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of angiotensin II receptor blocker on glucose-induced mRNA expressions of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in rat mesangial cells.
    Ding HL; Guo Y; Xu MT; Li HY; Fu ZZ
    Chin Med J (Engl); 2007 Nov; 120(21):1886-9. PubMed ID: 18067760
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 levels in patients with tick-borne encephalitis.
    Palus M; Zampachová E; Elsterová J; Růžek D
    J Infect; 2014 Feb; 68(2):165-9. PubMed ID: 24091083
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Low levels of tissue inhibitors of metalloproteinases with a high matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio are present in tracheal aspirate fluids of infants who develop chronic lung disease.
    Ekekezie II; Thibeault DW; Simon SD; Norberg M; Merrill JD; Ballard RA; Ballard PL; Truog WE
    Pediatrics; 2004 Jun; 113(6):1709-14. PubMed ID: 15173495
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Relationship Between Circulating Serpina3g, Matrix Metalloproteinase-9, and Tissue Inhibitor of Metalloproteinase-1 and -2 with Chronic Obstructive Pulmonary Disease Severity.
    Uysal P; Uzun H
    Biomolecules; 2019 Feb; 9(2):. PubMed ID: 30781876
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Expression and significance of matrix metalloproteinase and tissue inhibitor of metalloproteinase in nasal cavity squamous cell carcinoma].
    Zheng Y; Ding J; Wang CL; Jiao SS; Qu LM; Bahargul ; Bao H; Chen X
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Apr; 46(4):299-302. PubMed ID: 21624249
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Associations of matrix metalloproteinase (MMP)-8, MMP-9, and their inhibitor, tissue inhibitor of metalloproteinase-1, with obesity-related biomarkers in apparently healthy adolescent boys.
    Shin YH; Kim KE; Lee YJ; Nam JH; Hong YM; Shin HJ
    Korean J Pediatr; 2014 Dec; 57(12):526-32. PubMed ID: 25653686
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Effect of hypoxia on the expression of matrix metalloproteinase and tissue inhibitors of matrix metalloproteinase mRNA in human periodontal ligament fibroblasts in vitro].
    Song AM; Hou C; Chen JF; Sun J; Tian T; Li S
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2012 Oct; 47(10):599-604. PubMed ID: 23302382
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pre-treatment serum and plasma levels of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of matrix metalloproteinases 1 (TIMP-1) in gastric cancer patients.
    Mroczko B; Groblewska M; Łukaszewicz-Zajac M; Bandurski R; Kedra B; Szmitkowski M
    Clin Chem Lab Med; 2009; 47(9):1133-9. PubMed ID: 19728856
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Peripheral blood levels of matrix and inflammatory mediators are elevated in Tunisian patients with acute coronary syndromes.
    Zayani Y; Allal-Elasmi M; Jacob MP; Zidi W; Zaroui A; Feki M; Mourali S; Mechmech R; Kaabachi N
    Clin Lab; 2013; 59(1-2):169-75. PubMed ID: 23505923
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Plasma levels of tissue inhibitor of matrix metalloproteinase-1 correlate with diagnosis and prognosis of glioma patients.
    Lin Y; Wang JF; Gao GZ; Zhang GZ; Wang FL; Wang YJ
    Chin Med J (Engl); 2013 Nov; 126(22):4295-300. PubMed ID: 24238516
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Expression and significance of matrix metalloproteinase-1,9, tissue inhibitor of metalloproteinase-4 and extracellular matrix metalloproteinase inducer in the myocardium of congestive heart failure in patients with rheumatic heart diseases].
    Zhao Y; Zhou X; Liao X; Yang Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Aug; 34(8):790-5. PubMed ID: 19734590
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Impact of the metalloproteinase-9/tissue inhibitor of metalloproteinase-1 system on large arterial stiffness in patients with essential hypertension.
    Tan J; Hua Q; Xing X; Wen J; Liu R; Yang Z
    Hypertens Res; 2007 Oct; 30(10):959-63. PubMed ID: 18049028
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clinicopathologic and prognostic significance of matrix metalloproteinases in rectal cancer.
    Schwandner O; Schlamp A; Broll R; Bruch HP
    Int J Colorectal Dis; 2007 Feb; 22(2):127-36. PubMed ID: 16896992
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Expression of matrix metalloproteinase -2, -9 and tissue inhibitors of metalloproteinase -1, -2, -3 mRNAs in rat uterus during early pregnancy.
    Zhao YG; Xiao AZ; Cao XM; Zhu C
    Mol Reprod Dev; 2002 Jun; 62(2):149-58. PubMed ID: 11984824
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Clinical significance of serum matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 in the first phase of burn trauma evolution.
    Stanciu AE; Zamfir-Chiru-Anton A; Stanciu MM; Gherghe M; Hainarosie R; Furtunescu FL; Gheorghe DC
    Exp Ther Med; 2021 Oct; 22(4):1113. PubMed ID: 34504567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.